603301.SH上海证券交易所 · 主板 Main
Zhende Medical 振德医疗
Medical Devices 医疗器械
¥78.48−¥2.47 · −3.05%
Open 开盘
¥80.99
High 最高
¥81.53
Low 最低
¥78.02
Prev Close 昨收
¥80.95
Volume 成交量
187.9万股
Turnover 成交额
¥1.49亿
Mkt Cap 总市值
¥207亿
P/E 市盈率
74.8×
Recent Activity 近期动态All Filings 全部公告 →
One significant filing since 31 May 2026, on dividend (10 Jun 2026): 振德医疗2025年年度权益分派实施公告.
自 31 May 2026 起有一份重大公告（dividend，10 Jun 2026）：振德医疗2025年年度权益分派实施公告。
40.0050.0060.0070.0080.0090.00
Volume 成交量
3,416.3万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥207亿 | ¥47亿 | 13th highest of 140 · 140 家中第 13 高 | |
| Trailing P/E 市盈率 | 74.8x | 40.4x | 25th highest of 101 · 101 家中第 25 高 | |
| P/B 市净率 | 3.6x | 2.4x | 39th highest of 140 · 140 家中第 39 高 | |
| Revenue Growth 营收增速 | 5.9% | 4.0% | 62nd highest of 140 · 140 家中第 62 高 | |
| Profit Growth 净利增速 | 12.5% | -2.6% | 50th highest of 140 · 140 家中第 50 高 | |
| Gross Margin 毛利率 | 34.6% | 55.2% | 30th lowest of 140 · 140 家中第 30 低 | |
| Net Margin 净利率 | 6.8% | 10.7% | 53rd lowest of 140 · 140 家中第 53 低 | |
| Return on Equity 净资产收益率 | 2.5% | 2.4% | 68th highest of 140 · 140 家中第 68 高 | |
| Debt to Assets 资产负债率 | 28.8% | 19.2% | 45th highest of 140 · 140 家中第 45 高 | |
| Grade Score 评级得分 | 42 | 52 | 48th lowest of 140 · 140 家中第 48 低 |
Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗 | ¥1,864亿 | 23.7x | 4.6x | 6.0% | 28.4% | 12.0% | C |
| Shanghai United Imaging Healthcare 联影医疗 | ¥844亿 | 47.7x | 3.8x | 17.2% | 12.6% | 4.1% | D |
| Shenzhen New Industries Biomedical 新产业 | ¥375亿 | 21.8x | 4.2x | 10.8% | 35.9% | 9.3% | B |
| APT Medical 惠泰医疗 | ¥334亿 | 35.8x | 10.8x | 25.7% | 34.6% | 16.0% | B |
| Wantai Biological 万泰生物 | ¥334亿 | — | 2.8x | 24.3% | -12.6% | -1.1% | D |
| Intco Medical Technology 英科医疗 | ¥322亿 | 28.3x | 1.7x | 40.6% | 13.1% | 4.5% | C |
| MGI Tech 华大智造 | ¥312亿 | — | 4.4x | 18.9% | -11.6% | -2.2% | D |
| Andon Health 九安医疗 | ¥288亿 | 6.5x | 1.2x | -30.6% | 578.7% | 13.7% | C |
| IRAY Group 奕瑞科技 | ¥279亿 | 38.7x | 3.6x | 56.7% | 25.0% | 6.4% | C |
| Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗 | ¥262亿 | 23.4x | 2.0x | -1.9% | 18.6% | 6.2% | C |
| Weigao Blood Purification 威高血净 | ¥216亿 | 44.0x | 1.8x | -0.4% | 13.1% | 3.2% | D |
| Lepu Medical Technology 乐普医疗 | ¥210亿 | 27.3x | 1.3x | -4.6% | 14.2% | 3.0% | D |
| Zhende Medical 振德医疗 | ¥207亿 | 74.8x | 3.6x | 5.9% | 6.8% | 2.5% | D |
| Autobio 安图生物 | ¥192亿 | 19.3x | 2.2x | -0.1% | 24.4% | 5.5% | C |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。